🔗 Permalink

Inventor profile of:

James D. Marks

City:

Kensington, California

Country:

United States

Published Applications:

Last publication date:

2024-01-25

Top Assignees for applications by James D. Marks

The entities that hold a legal rights for patent applications filed by inventor Marks James D.:

The Regents of the University of California 46 Oakland, CA United States
Fox Chase Cancer Center 5 Philadelphia, PA United States
DENDROCYTE BIOTECH PTY LTD 3 Balmain, Australia
The Regents of the California University 2 Oakland, CA United States
The University of Queensland 2 Queensland, Australia
HERMES BIOSCIENCES, INC. 1 South San Francisco, CA United States
KIRA BIOTECH PTY LIMITED 1 Fortitude Valley, Australia
The University of Queensland 1 St. Lucia, Australia
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE 1 Oakland, CA United States
Merrimack Pharmaceuticals, Inc. 1 Massachusetts, Morocco
THE REGENTS OF THE UNIVERSITY OF CALFORNIA 1 Oakland, CA United States

Recent patent applications by Marks James D.

James D. Marks from Kensington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-25

US20240026027A1

Chemistry; metallurgy

INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE CANCER CELLS IN SITU

#2 | 2023-09-07

US20230279084A1

Chemistry; metallurgy

ANTIBODIES TO BOTULINUM NEUROTOXINS

#3 | 2022-09-08

US20220281990A1

Chemistry; metallurgy

ANTI-TNFR2 ANTIBODIES AND USES THEREOF

#4 | 2022-08-11

US20220251240A1

Chemistry; metallurgy

Antibodies for Botulinum Neurotoxins

#5 | 2022-03-24

US20220089784A1

Chemistry; metallurgy

Antibodies for Botulinum Neurotoxins

#6 | 2020-10-29

US20200339684A1

Chemistry; metallurgy

Anti-CD83 antibodies and use thereof

#7 | 2020-10-15

US20200325247A1

Chemistry; metallurgy

Antibodies for botulinum neurotoxins

#8 | 2020-08-13

US20200255537A1

Chemistry; metallurgy

INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE CANCER CELLS IN SITU

#9 | 2019-12-12

US20190375828A1

Chemistry; metallurgy

Antibodies that neutralize botulinum neurotoxins

#10 | 2018-07-26

US20180208680A1

Chemistry; metallurgy

Antibodies for botulinum neurotoxins

#11 | 2018-07-26

US20180208679A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#12 | 2018-07-19

US20180201681A1

Chemistry; metallurgy

Anti-CD83 antibodies and use thereof

#13 | 2017-09-21

US20170267768A1

Chemistry; metallurgy

Protein A Binding Polypeptides, Anti-EphA2 Antibodies and Methods of Use Thereof

#14 | 2017-08-17

US20170233488A1

Chemistry; metallurgy

Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

#15 | 2017-04-06

US20170096474A1

Chemistry; metallurgy

Antibodies that neutralize botulinum neurotoxins

#16 | 2016-12-29

US20160376369A1

Chemistry; metallurgy

Anti-EphA2 antibodies and methods of use thereof

#17 | 2016-09-29

US20160279262A1

Human necessities

Internalizing ErbB2 Antibodies

#18 | 2016-08-11

US20160229921A1

Chemistry; metallurgy

Antibodies for botulinum neurotoxins

#19 | 2016-06-16

US20160168265A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#20 | 2016-05-19

US20160137737A1

Chemistry; metallurgy

Integrin αvβ8 neutralizing antibody

#21 | 2016-04-07

US20160096883A1

Chemistry; metallurgy

GLIOBLASTOMA MULTIFORME-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF

#22 | 2015-12-31

US20150376277A1

Chemistry; metallurgy

Anti-CD83 antibodies and use thereof

#23 | 2015-12-03

US20150343081A1

Human necessities

Anti-EphA2 antibodies and methods of use thereof

#24 | 2015-08-27

US20150239983A1

Chemistry; metallurgy

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

#25 | 2015-07-16

US20150197559A1

Chemistry; metallurgy

Antibodies that neutralize botulinum neurotoxins

#26 | 2015-03-12

US20150071937A1

Chemistry; metallurgy

Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

#27 | 2015-01-29

US20150030600A1

Chemistry; metallurgy

Antibodies for botulinum neurotoxins

#28 | 2014-04-17

US20140105910A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#29 | 2013-12-19

US20130337039A1

Chemistry; metallurgy

Internalizing erbB2 antibodies

#30 | 2013-08-15

US20130209481A1

Chemistry; metallurgy

Anti-tumor antigen antibodies and methods of use

#31 | 2013-08-08

US20130202603A1

Human necessities

Bispecific single chain Fv antibody molecules and methods of use therof

#32 | 2013-03-14

US20130064837A1

Chemistry; metallurgy

Integrin α-Vβ8 neutralizing antibody

#33 | 2013-02-21

US20130045206A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST THE TRANSFERRIN RECEPTOR AND USES THEREOF FOR IMMUNOTHERAPY OF IRON-DEPENDENT TUMOURS

#34 | 2012-10-25

US20120269822A1

Chemistry; metallurgy

Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies

#35 | 2012-07-12

US20120177663A1

Chemistry; metallurgy

Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins

#36 | 2012-02-16

US20120039915A1

Chemistry; metallurgy

Glioblastoma multiforme-reactive antibodies and methods of use thereof

#37 | 2011-09-08

US20110218333A1

Human necessities

Internalizing ErbB2 antibodies

#38 | 2011-08-18

US20110200615A1

Chemistry; metallurgy

Antibodies that neutralize botulinum neurotoxins

#39 | 2011-07-14

US20110171235A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#40 | 2010-11-25

US20100297004A1

Chemistry; metallurgy

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

#41 | 2010-09-16

US20100233165A1

Chemistry; metallurgy

Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

#42 | 2010-08-05

US20100196265A1

Chemistry; metallurgy

Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof

#43 | 2010-07-01

US20100166773A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#44 | 2010-01-14

US20100009390A1

Chemistry; metallurgy

MUTANT ANTIBODIES WITH HIGH AFFINITY FOR EGFR

#45 | 2010-01-14

US20100008978A1

Human necessities

NANOPARTICLES EFFECTIVE FOR INTERNALIZATION INTO CELLS

#46 | 2009-12-31

US20090324606A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#47 | 2009-07-21

US10632706

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#48 | 2009-05-14

US20090123481A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#49 | 2009-04-23

US20090105086A1

Chemistry; metallurgy

Methods of selecting internalizing antibodies

#50 | 2009-01-08

US20090010841A1

Chemistry; metallurgy

Prostate cancer specific internalizing human antibodies

#51 | 2009-01-08

US20090010840A1

Human necessities

Bispecific single chain Fv antibody molecules and methods of use thereof

#52 | 2008-05-29

US20080124328A1

Chemistry; metallurgy

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

#53 | 2008-05-08

US20080108135A1

Human necessities

Internalizing ErbB2 antibodies

#54 | 2008-02-19

US10406830

Bispecific single chain Fv antibody molecules and methods of use thereof

#55 | 2007-07-17

US9250056

Internalizing ERB2 antibodies

#56 | 2006-12-21

US20060287509A1

Chemistry; metallurgy

High affinity human antibodies to tumor antigens

#57 | 2006-11-23

US20060263801A1

Physics

Methods of high-throughput screening for internalizing antibodies

#58 | 2006-05-16

US9981636

Methods of high-throughput screening for internalizing antibodies

#59 | 2006-05-11

US20060099205A1

Human necessities

Bispecific single chain Fv antibody molecules and methods of use thereof

#60 | 2005-08-25

US20050186214A1

Chemistry; metallurgy

Prostate cancer specific internalizing human antibodies

#61 | 2005-02-17

US20050037339A1

Chemistry; metallurgy

Methods of selecting internalizing antibodies

InventorID:

100316 ⎘